🇺🇸 FDA
Patent

US 10888609

CD200 inhibitors and methods of use thereof

granted A61KA61K2039/545A61K2039/55516

Quick answer

US patent 10888609 (CD200 inhibitors and methods of use thereof) held by Regents of the University of Minnesota expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/545, A61K2039/55516, A61K2039/55561, A61K2039/585